Literature DB >> 21211943

Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?

Matthew M Kurtz1, Arielle Tolman.   

Abstract

Subjective quality-of-life (SQOL) has been recognized as a crucial domain of outcome in schizophrenia treatment, and yet its determinants are not well understood. In a recent meta-analytic investigation of 10 studies of neurocognition and SQOL in schizophrenia (Tolman and Kurtz, Scz Bull, 2010) measures of crystallized verbal ability and processing speed were moderately negatively correlated with SQOL. One potential explanation for inverse relationships between measures of elementary neurocognition and SQOL is that higher levels of cognition may serve as a proxy for better insight into the illness, and better consequent recognition of illness-related functional impairment. This study sought to determine whether: (1) symptoms, neurocognitive variables, and insight into illness influence SQOL; and, (2) whether insight mediated or moderated a relationship between elementary neurocognitive function and SQOL. Seventy-one stabilized clients with schizophrenia or schizoaffective disorder were administered a neuropsychological test battery, symptom and subjective quality-of-life measures. Elementary neuropsychological measures of crystallized verbal ability, attention and working memory, and problem-solving were all inversely related to SQOL. Insight into illness and depression severity, but not positive and negative symptoms, was also inversely related to SQOL. Insight was not found to mediate or moderate any of the relationships between elementary neurocognition and SQOL. Taken together, these findings suggest that neurocognition and insight into illness have inverse relationships to SQOL and that elementary neurocognition does not influence SQOL through its link with illness insight.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21211943      PMCID: PMC3051009          DOI: 10.1016/j.schres.2010.12.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  30 in total

1.  The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration.

Authors:  Matthew M Kurtz; J Daniel Ragland; Paul J Moberg; Ruben C Gur
Journal:  Arch Clin Neuropsychol       Date:  2004-03       Impact factor: 2.813

Review 2.  Insight in psychosis and neuropsychological function: meta-analysis.

Authors:  André Aleman; Niruj Agrawal; Kevin D Morgan; Anthony S David
Journal:  Br J Psychiatry       Date:  2006-09       Impact factor: 9.319

3.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

4.  The construct validity of subjective quality of life for the severely mentally ill.

Authors:  P W Corrigan; B Buican
Journal:  J Nerv Ment Dis       Date:  1995-05       Impact factor: 2.254

Review 5.  Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

Authors:  Michael F Green; Robert S Kern; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

6.  The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder.

Authors:  T E Smith; J W Hull; M Goodman; A Hedayat-Harris; D F Willson; L M Israel; R L Munich
Journal:  J Nerv Ment Dis       Date:  1999-02       Impact factor: 2.254

7.  Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates.

Authors:  F B Dickerson; N B Ringel; F Parente
Journal:  Acta Psychiatr Scand       Date:  1998-08       Impact factor: 6.392

8.  Assessment of insight in psychosis.

Authors:  X F Amador; D H Strauss; S A Yale; M M Flaum; J Endicott; J M Gorman
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

9.  Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation.

Authors:  L I Stein; M A Test
Journal:  Arch Gen Psychiatry       Date:  1980-04

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  16 in total

1.  Metacognition: towards a new approach to quality of life.

Authors:  Julien Blanc; Laurent Boyer; Pierre Le Coz; Pascal Auquier
Journal:  Qual Life Res       Date:  2013-08-29       Impact factor: 4.147

2.  Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Karine Baumstarck; Stephen E Gilman
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

Review 3.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

4.  Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR.

Authors:  Philip D Harvey; Cynthia O Siu; Antony D Loebel
Journal:  Innov Clin Neurosci       Date:  2017-12-01

5.  The structural neuroanatomy of metacognitive insight in schizophrenia and its psychopathological and neuropsychological correlates.

Authors:  Gianfranco Spalletta; Fabrizio Piras; Federica Piras; Carlo Caltagirone; Maria Donata Orfei
Journal:  Hum Brain Mapp       Date:  2014-04-03       Impact factor: 5.038

6.  Outcome prediction with a social cognitive battery: a multicenter longitudinal study.

Authors:  Eric Brunet-Gouet; Capucine Decaix-Tisserand; Mathieu Urbach; Nadine Bazin; Bruno Aouizerate; Lore Brunel; Delphine Capdevielle; Isabelle Chereau; Caroline Dubertret; Julien Dubreucq; Guillaume Fond; Christophe Lançon; Sylvain Leignier; Jasmina Mallet; David Misdrahi; Sylvie Pires; Priscille Schneider; Franck Schurhoff; Hanan Yazbek; Anna Zinetti-Bertschy; Christine Passerieux; Paul Roux
Journal:  NPJ Schizophr       Date:  2021-05-26

7.  Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia.

Authors:  Muzaffer Kaser; Fruzsina Soltesz; Phil Lawrence; Sam Miller; Chris Dodds; Rodney Croft; Robert B Dudas; Rashid Zaman; Emilio Fernandez-Egea; Ulrich Müller; Anna Dean; Edward T Bullmore; Pradeep J Nathan
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

8.  The assessment of quality of life in clinical practice in patients with schizophrenia.

Authors:  Anne Karow; Linus Wittmann; Daniel Schöttle; Ingo Schäfer; Martin Lambert
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

9.  Validity of subjective versus objective quality of life assessment in people with schizophrenia.

Authors:  Karen P Hayhurst; Jennifer A Massie; Graham Dunn; Shôn W Lewis; Richard J Drake
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

10.  Daily Ecological Momentary Assessments of happy and sad moods in people with schizophrenia and bipolar disorders: What do participants who are never sad think about their activities and abilities?

Authors:  Sara E Jones; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.